Michael Boyce, PhD, Associate Professor of Biochemistry and co-director of the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) program, a national program to enhance faculty diversity at research universities, organized by the American Society for Cell Biology (ASCB) and funded by National Institutes of Health (NIH).

Anthony S. Fauci, MD, visited Duke at the invitation of Bart Haynes, MD, Frederic M. Hanes Distinguished Professor of Medicine and director of the Duke Human Vaccine Institute (DHVI). He took the audience on a journey though time spanning his 58-year medical career.

Four staff members from across the School of Medicine have been named recipients of the Dean’s Staff Awards for 2024. The Dean’s Staff Awards are presented annually to recognize exemplary staff supporting the School of Medicine’s mission and values.  

Intervening to reduce alcohol use is associated with a lower likelihood that an individual will receive a new opioid prescription or develop an opioid use disorder, according to a study led by researchers at Duke University and the Durham Veterans Affairs (VA) Medical Center.

Globally, the need for mental health care far outstrips the number of professionally trained providers. Duke global health researchers and clinicians are helping address that need by training non-specialists to provide mental health support in communities without access to specialized resources.

Dr. Klotman shares news about faculty awards, graduation and more.

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

The Duke University School of Medicine has announced the 2024 Michelle P.

Dr. Kathleen A. Cooney, Chair of the Duke Department of Medicine (DOM) and renowned medical oncologist, has been elected as the incoming president of the Association of Professors of Medicine (APM).

Zhang’s group at Duke is studying the half of the human genome that is made up of long, repetitive sequences of DNA called transposons, or “jumping genes.” They’re given that nickname because of their habit of jumping around in the genome, making changes and enabling evolution.